ContextLogic Inc. (LOGC)
USD 7.18
(2.79%)
USD 7.18
(2.79%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -232 Million USD | 52.94% |
| 2022 | -493 Million USD | 50.35% |
| 2021 | -993 Million USD | 48.47% |
| 2020 | -1.92 Billion USD | -8354.35% |
| 2019 | -22.79 Million USD | 71.83% |
| 2018 | -80.9 Million USD | -229.22% |
| 2017 | -24.57 Million USD | -1322.16% |
| 2016 | -1.72 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -246 Million USD | -6.03% |
| 2024 Q2 | -103 Million USD | 58.13% |
| 2023 FY | -232 Million USD | 52.94% |
| 2023 Q3 | -296 Million USD | 4.21% |
| 2023 Q1 | -360 Million USD | 0.0% |
| 2023 Q4 | -232 Million USD | 21.62% |
| 2023 Q2 | -309 Million USD | 14.17% |
| 2022 Q1 | -30.56 Million USD | 24.02% |
| 2022 Q4 | - USD | 100.0% |
| 2022 Q3 | -20.8 Million USD | 25.06% |
| 2022 FY | -493 Million USD | 50.35% |
| 2022 Q2 | -27.75 Million USD | 9.18% |
| 2021 Q1 | -48.08 Million USD | 10.97% |
| 2021 FY | -993 Million USD | 48.47% |
| 2021 Q4 | -40.22 Million USD | 11.12% |
| 2021 Q3 | -45.26 Million USD | 14.17% |
| 2021 Q2 | -52.73 Million USD | -9.66% |
| 2020 Q2 | -20.38 Million USD | 38.39% |
| 2020 Q1 | -33.09 Million USD | -45.18% |
| 2020 FY | -1.92 Billion USD | -8354.35% |
| 2020 Q4 | -54.01 Million USD | -237.79% |
| 2020 Q3 | -15.98 Million USD | 21.58% |
| 2019 Q2 | -24.48 Million USD | 8.17% |
| 2019 Q1 | -26.66 Million USD | 67.04% |
| 2019 FY | -22.79 Million USD | 71.83% |
| 2019 Q4 | -22.79 Million USD | 19.32% |
| 2019 Q3 | -28.25 Million USD | -15.37% |
| 2018 Q4 | -80.9 Million USD | -528.3% |
| 2018 FY | -80.9 Million USD | -229.22% |
| 2018 Q2 | -18.26 Million USD | 0.0% |
| 2018 Q3 | -12.87 Million USD | 29.48% |
| 2017 Q4 | -24.57 Million USD | 0.0% |
| 2017 FY | -24.57 Million USD | -1322.16% |
| 2016 FY | -1.72 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1356.097% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2954.239% |
| Vaxxinity, Inc. | 10.13 Million USD | 2389.775% |
| IO Biotech, Inc. | -140.69 Million USD | -64.891% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 18600.797% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 5682.291% |
| MEI Pharma, Inc. | -3.7 Million USD | -6161.808% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -64.854% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 4.276% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -13357.077% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 21.024% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 26.745% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 232637.161% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 241.147% |
| Agenus Inc. | 274.13 Million USD | 184.63% |
| AlloVir, Inc. | -62.69 Million USD | -270.063% |
| CRISPR Therapeutics AG | -150.84 Million USD | -53.8% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 243.438% |
| NextCure, Inc. | -6.47 Million USD | -3481.905% |
| Opthea Limited | 28.15 Million USD | 923.938% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2007.382% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 934.743% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1152.71% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -315.294% |
| Senti Biosciences, Inc. | 1.74 Million USD | 13433.333% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 478.732% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -307861.876% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 112.407% |
| BioLineRx Ltd. | 7.33 Million USD | 3262.486% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -931.34% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -79.686% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -3310.26% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 4447.011% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -865.179% |
| AbCellera Biologics Inc. | -55.94 Million USD | -314.73% |
| ADMA Biologics, Inc. | 90.06 Million USD | 357.589% |
| Aptorum Group Limited | 1.35 Million USD | 17195.957% |
| AnaptysBio, Inc. | -18.15 Million USD | -1178.166% |
| Ardelyx, Inc. | 34.51 Million USD | 772.23% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 5520.561% |
| Bicycle Therapeutics plc | -481.46 Million USD | 51.814% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 741.54% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -317.161% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1747.61% |
| Chimerix, Inc. | -25.51 Million USD | -809.198% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 3429.47% |
| Dyadic International, Inc. | -6.37 Million USD | -3537.447% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1113.516% |
| ESSA Pharma Inc. | -33.62 Million USD | -590.033% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3126.745% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 476.22% |
| GlycoMimetics, Inc. | -40.98 Million USD | -466.069% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3126.745% |
| ChromaDex Corporation | -24.04 Million USD | -864.737% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2411.587% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 38.493% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -879.854% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -50.507% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -242.269% |
| Incyte Corporation | -3.17 Billion USD | 92.693% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1559.268% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2662.563% |
| Jaguar Health, Inc. | 29.39 Million USD | 889.357% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 105.054% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -4626.013% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1281.857% |
| Lantern Pharma Inc. | -21.7 Million USD | -968.963% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1442.748% |
| MiMedx Group, Inc. | -33.9 Million USD | -584.346% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2171.392% |
| Structure Therapeutics Inc. | -124.33 Million USD | -86.587% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -109.884% |
| Onconetix, Inc. | 5.33 Million USD | 4451.547% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -3536.934% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 3464.953% |
| PDS Biotechnology Corporation | -32.7 Million USD | -609.287% |
| Precigen, Inc. | -481 Thousand USD | -48132.848% |
| Pharming Group N.V. | 109.8 Million USD | 311.286% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1233.64% |
| PureTech Health plc | -167.19 Million USD | -38.758% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -471.823% |
| Royalty Pharma plc | 5.65 Billion USD | 104.1% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1152.71% |
| Seer, Inc. | -4.24 Million USD | -5371.698% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -3167.606% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -3859.044% |
| Acelyrin, Inc. | -216.9 Million USD | -6.96% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -4035.276% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2375.625% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -9912.831% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -199.544% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1398.847% |
| Alkermes plc | -166.73 Million USD | -39.14% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 37042.675% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -3637.113% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -703.547% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -359.397% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -98.213% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -37.904% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -32.397% |
| Geron Corporation | 14.76 Million USD | 1671.709% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1954.368% |
| Summit Therapeutics Inc. | 34.67 Million USD | 769.089% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -25.672% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3727.12% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2615.618% |
| Innoviva, Inc. | 255.56 Million USD | 190.78% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1574.365% |
| Vaxcyte, Inc. | -368.22 Million USD | 36.995% |
| Molecular Templates, Inc. | 707 Thousand USD | 32914.71% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -661.655% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 309.254% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1852.398% |
| Novavax, Inc. | -298.29 Million USD | 22.224% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 5176.586% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -186133.193% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -73.032% |
| Precision BioSciences, Inc. | -85.41 Million USD | -171.631% |
| GT Biopharma, Inc. | -1.02 Million USD | -22622.821% |
| ImmuCell Corporation | 10.99 Million USD | 2210.902% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1224.973% |
| Mesoblast Limited | 55.96 Million USD | 514.56% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -651.734% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2731.044% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -7314.467% |
| Soligenix, Inc. | -4.95 Million USD | -4585.357% |
| Century Therapeutics, Inc. | 847 Thousand USD | 27490.791% |
| Kura Oncology, Inc. | -20.11 Million USD | -1053.196% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -466.877% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 12835.392% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -7156.803% |
| Autolus Therapeutics plc | -186.59 Million USD | -24.331% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -370.55% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 15.879% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 777.016% |
| GRI Bio, Inc. | -1.79 Million USD | -12831.996% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2482.643% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -597.597% |
| IGM Biosciences, Inc. | -72.6 Million USD | -219.533% |
| INmune Bio, Inc. | -25.41 Million USD | -812.99% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 253.692% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -357.964% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1327.747% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -7941.801% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 710.285% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -463.312% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 827.615% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 161.384% |
| Verastem, Inc. | -37.27 Million USD | -522.351% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2457.037% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -347.341% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1432.871% |
| Histogen Inc. | -7.48 Million USD | -2998.704% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -973.735% |
| Surrozen, Inc. | -32.66 Million USD | -610.262% |
| Organovo Holdings, Inc. | -1.5 Million USD | -15294.824% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5419.226% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1323.615% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 8968.502% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2668.117% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -434.045% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1491.564% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 26.765% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -32030.294% |
| Apollomics, Inc. | -27.39 Million USD | -746.87% |
| Amarin Corporation plc | -191.04 Million USD | -21.441% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1490.784% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -817.286% |
| Synaptogenix, Inc. | -28.66 Million USD | -709.448% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -24686.325% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 576.073% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -26811.375% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -3092.918% |
| Exelixis, Inc. | -73.05 Million USD | -217.591% |
| Better Therapeutics, Inc. | -860 Thousand USD | -26876.744% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -866.143% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 3.882% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 31618.913% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -3019.061% |
| Gritstone bio, Inc. | 39.49 Million USD | 687.491% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -175.859% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -8714.121% |
| Avid Bioservices, Inc. | 169.72 Million USD | 236.689% |
| Insmed Incorporated | 721.62 Million USD | 132.15% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2437.873% |
| MediWound Ltd. | -5.32 Million USD | -4259.263% |
| OmniAb, Inc. | 9.2 Million USD | 2620.917% |
| Alector, Inc. | -35.63 Million USD | -551.009% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 369.858% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -4607.792% |
| Zai Lab Limited | -775 Million USD | 70.065% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 168.124% |
| Aura Biosciences, Inc. | -21.52 Million USD | -977.816% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -181.28% |
| Immunic, Inc. | -45.34 Million USD | -411.689% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -20.073% |
| Veracyte, Inc. | -203.82 Million USD | -13.824% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 136.347% |
| FibroGen, Inc. | 56.76 Million USD | 508.688% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2705.278% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -8106.341% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -11105.846% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -6844.029% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -39.789% |
| Galecto, Inc. | -21.21 Million USD | -993.514% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -875.405% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 114.783% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -848.022% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1916.164% |
| XBiotech Inc. | -200.02 Million USD | -15.987% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -175.859% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 5223.675% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -557.913% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -200.448% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 4176.612% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -36.138% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -151.153% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 131.51% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2054.622% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -251.75% |
| NexImmune, Inc. | -3.13 Million USD | -7303.524% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -6619.432% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1435.26% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -756.089% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2484.655% |
| Ainos, Inc. | 4.07 Million USD | 5789.164% |
| Pluri Inc. | 22.82 Million USD | 1116.251% |
| Prothena Corporation plc | -608.34 Million USD | 61.864% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -95.359% |
| Celularity Inc. | 65.19 Million USD | 455.883% |
| Rallybio Corporation | -24.1 Million USD | -862.576% |
| Cue Biopharma, Inc. | -33.81 Million USD | -586.005% |
| MeiraGTx Holdings plc | -40.3 Million USD | -475.654% |
| Omeros Corporation | 331.17 Million USD | 170.053% |
| Humacyte, Inc. | -22.48 Million USD | -931.753% |
| Immunocore Holdings plc | -358.59 Million USD | 35.303% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -844.049% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -650.785% |
| Blueprint Medicines Corporation | 702.83 Million USD | 133.009% |
| CalciMedica, Inc. | -5.53 Million USD | -4095.298% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -23.26% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -479.464% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -597.681% |
| Pulmatrix, Inc. | -10.41 Million USD | -2127.129% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3781.546% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -508.253% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -108.255% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -287.028% |
| Cytokinetics, Incorporated | 642.37 Million USD | 136.116% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -3884.201% |
| Nutriband Inc. | -251.65 Thousand USD | -92088.971% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -579.973% |
| Vor Biopharma Inc. | 4.3 Million USD | 5495.349% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.156% |
| Evogene Ltd. | -19.63 Million USD | -1081.624% |
| ProKidney Corp. | -56.23 Million USD | -312.547% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -376.66% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 117.01% |
| CorMedix Inc. | -43.05 Million USD | -438.877% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -744.711% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 602.741% |
| Atai Life Sciences N.V. | -28.55 Million USD | -712.382% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 10501.12% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -916.83% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1408.148% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -209.028% |
| MediciNova, Inc. | -50.78 Million USD | -356.841% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -194.398% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1031240.298% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3495.456% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -16.104% |
| Biomea Fusion, Inc. | -166.57 Million USD | -39.281% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -29.627% |
| Mereo BioPharma Group plc | -51.46 Million USD | -350.757% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -144.612% |
| Absci Corporation | -72.59 Million USD | -219.568% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5181.034% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 1.04% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -146.256% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -142.434% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -493.76% |
| Allakos Inc. | -24.97 Million USD | -828.929% |
| Imunon, Inc. | -4.21 Million USD | -5405.651% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1473.735% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -71.344% |
| BioAtla, Inc. | -109.01 Million USD | -112.823% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 31618.913% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -24607.135% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2038.827% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -994.185% |
| XOMA Corporation | -29 Million USD | -700.0% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1300.966% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2473.203% |
| aTyr Pharma, Inc. | -7.44 Million USD | -3014.512% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -86.142% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -11.451% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -183.691% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -150.1% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -26902.365% |
| Akari Therapeutics, Plc | -3.84 Million USD | -5933.81% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 14395.485% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 116.801% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -19426.401% |
| UroGen Pharma Ltd. | 4.39 Million USD | 5383.535% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 304.44% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 322492.374% |
| Orgenesis Inc. | 21.78 Million USD | 1165.002% |
| Entera Bio Ltd. | -10.62 Million USD | -2082.708% |
| GH Research PLC | -78.07 Million USD | -197.143% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -940.919% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -770.25% |
| Xencor, Inc. | 29.64 Million USD | 882.62% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -11677.774% |
| Replimune Group, Inc. | 1.41 Million USD | 16530.595% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -94629.449% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -83.52% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -19426.401% |
| Portage Biotech Inc. | -4.98 Million USD | -4557.699% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1031240.298% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -250.867% |
| OncoCyte Corporation | -6.56 Million USD | -3434.969% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 25952.088% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -4992.585% |
| Purple Biotech Ltd. | -14.13 Million USD | -1540.968% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -876.595% |
| scPharmaceuticals Inc. | -6.54 Million USD | -3444.691% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1289.874% |
| HilleVax, Inc. | -165.48 Million USD | -40.194% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -9041.056% |
| Tharimmune, Inc. | -10.93 Million USD | -2021.56% |
| Genprex, Inc. | -6.73 Million USD | -3343.348% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 37.094% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -162.265% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -16459.6% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -6894.386% |
| OKYO Pharma Limited | -826.84 Thousand USD | -27958.361% |
| Savara Inc. | 153 Thousand USD | 151733.987% |
| Curis, Inc. | -23.88 Million USD | -871.24% |
| Daré Bioscience, Inc. | -5.15 Million USD | -4397.945% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -29796.445% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 19678.059% |
| BeiGene, Ltd. | -2.25 Billion USD | 89.703% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1980.293% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 61.855% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -25.009% |
| Erasca, Inc. | -37.21 Million USD | -523.388% |
| bluebird bio, Inc. | 108.57 Million USD | 313.685% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -17913.919% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 161.254% |
| DBV Technologies S.A. | -126.98 Million USD | -82.697% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -17913.919% |
| Moderna, Inc. | -2.9 Billion USD | 92.019% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2141.113% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2034.707% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -639.537% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 166.934% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -182.713% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -152.916% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -618.889% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -574.889% |
| MacroGenics, Inc. | -66.98 Million USD | -246.346% |
| RenovoRx, Inc. | -1.17 Million USD | -19678.346% |
| Adicet Bio, Inc. | -138.78 Million USD | -67.163% |
| Prime Medicine, Inc. | -27.94 Million USD | -730.321% |
| Aditxt, Inc. | 18.12 Million USD | 1380.291% |
| Adagene Inc. | -87.62 Million USD | -164.757% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -5469.656% |
| Quantum-Si incorporated | -118.55 Million USD | -95.686% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 744.355% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -3004.016% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -378.262% |
| SciSparc Ltd. | -2.06 Million USD | -11134.867% |
| Vericel Corporation | 1.27 Million USD | 18267.58% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1834.671% |
| Minerva Neurosciences, Inc. | 41 Million USD | 665.795% |
| Generation Bio Co. | 31.44 Million USD | 837.726% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -32.296% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -650.251% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 298.983% |
| Invivyd, Inc. | -198.47 Million USD | -16.891% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -157.007% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -9575.987% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -227.73% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -3299.267% |
| 2seventy bio, Inc. | 181.71 Million USD | 227.672% |
| Clene Inc. | 3.34 Million USD | 7046.108% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2454.306% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -978.518% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3495.456% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 32.582% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -792.319% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 230.582% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -5570.199% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 4738.145% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -4353.83% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -78.045% |
| Evaxion Biotech A/S | 5.28 Million USD | 4488.251% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -106.098% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -76.731% |
| Trevena, Inc. | 2.25 Million USD | 10374.579% |
| Surrozen, Inc. | -32.66 Million USD | -610.262% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -350.398% |
| Cingulate Inc. | 3.08 Million USD | 7625.912% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -7799.217% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 3328.051% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2396.979% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -192.475% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -76.49% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -119.818% |
| Clearmind Medicine Inc. | -3.94 Million USD | -5784.387% |
| Kronos Bio, Inc. | -36.05 Million USD | -543.479% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2565.724% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 16010.823% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -327.602% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1709.278% |
| ImmunityBio, Inc. | 618.22 Million USD | 137.527% |
| Korro Bio, Inc. | -132.94 Million USD | -74.511% |
| Kineta, Inc. | -4.54 Million USD | -5009.007% |
| BioVie Inc. | -17.73 Million USD | -1208.343% |
| Codexis, Inc. | -43.27 Million USD | -436.156% |
| Celularity Inc. | 65.19 Million USD | 455.883% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -7220.921% |
| Celcuity Inc. | 6.78 Million USD | 3520.059% |
| Virax Biolabs Group Limited | -3.36 Million USD | -6794.617% |
| Cibus, Inc. | -8.07 Million USD | -2771.998% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -5385.93% |
| IN8bio, Inc. | -16.38 Million USD | -1315.584% |
| Kodiak Sciences Inc. | -103.87 Million USD | -123.345% |
| Annexon, Inc. | -193.75 Million USD | -19.739% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 644544.444% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1225.79% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -6504.042% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 122.006% |
| Eyenovia, Inc. | 1.25 Million USD | 18531.686% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 962.293% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -7053.87% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -597.807% |
| Arcellx, Inc. | -296.95 Million USD | 21.874% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1089.378% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -294.055% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1019.313% |
| Moolec Science SA | 117.61 Thousand USD | 197352.075% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -504.182% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -511.847% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -64.049% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -3219.301% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -4226.051% |
| Humacyte, Inc. | -22.48 Million USD | -931.753% |
| 89bio, Inc. | -289.05 Million USD | 19.738% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -819.103% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -12911.778% |
| Genelux Corporation | -6.89 Million USD | -3262.806% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -646.965% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 377.515% |
| Notable Labs, Ltd. | -9.77 Million USD | -2273.159% |
| Liquidia Corporation | -80.17 Million USD | -189.363% |
| Mustang Bio, Inc. | -3.73 Million USD | -6109.85% |
| Immunovant, Inc. | -635.22 Million USD | 63.478% |
| Quantum-Si incorporated | -118.55 Million USD | -95.686% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1220.884% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -5499.807% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2990.245% |
| Acasti Pharma Inc. | -23 Million USD | -908.476% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -6789.938% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1327.747% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -68.433% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -7344.578% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -943.541% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1149.394% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -37.053% |
| PepGen Inc. | -60.67 Million USD | -282.397% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -909.749% |
| United Therapeutics Corporation | -507.7 Million USD | 54.304% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1113.008% |
| Solid Biosciences Inc. | -47.75 Million USD | -385.864% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -26811.375% |
| Immuneering Corporation | -54.94 Million USD | -322.257% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5419.226% |
| Silo Pharma, Inc. | -3.52 Million USD | -6482.853% |
| Belite Bio, Inc | -87.27 Million USD | -165.839% |
| XOMA Corporation | -29 Million USD | -700.0% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -228.161% |
| Bionomics Limited | 227 Million USD | 202.198% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -99.515% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -9059.1% |
| uniQure N.V. | -102.95 Million USD | -125.35% |
| Cassava Sciences, Inc. | -121.13 Million USD | -91.52% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -5469.656% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 666.531% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1839.637% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -7397.899% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 218967.925% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -7053.87% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2705.278% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -3028.371% |
| Altimmune, Inc. | -134.48 Million USD | -72.507% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 217.133% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -9059.1% |
| Compugen Ltd. | -12.9 Million USD | -1697.892% |
| Peak Bio, Inc. | 10.34 Million USD | 2343.679% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -81878.799% |
| Benitec Biopharma Inc. | -50.58 Million USD | -358.661% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -122.354% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1280.962% |
| Zura Bio Limited | -99.8 Million USD | -132.451% |
| PolyPid Ltd. | 6.17 Million USD | 3860.13% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 413.006% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1280.962% |
| Instil Bio, Inc. | 75.35 Million USD | 407.864% |
| argenx SE | -2.02 Billion USD | 88.565% |
| Immunome, Inc. | -97.02 Million USD | -139.104% |
| Verona Pharma plc | -220.44 Million USD | -5.243% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -223.376% |
| Shattuck Labs, Inc. | -121.42 Million USD | -91.066% |
| CervoMed Inc. | -7.79 Million USD | -2877.089% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -25.068% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -5205.282% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -76.104% |
| Moolec Science SA | 117.61 Thousand USD | 197352.075% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -10039.962% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1178.237% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -229.634% |
| NeurAxis, Inc. | 145.7 Thousand USD | 159331.297% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2165.527% |
| Lumos Pharma, Inc. | -28.49 Million USD | -714.235% |
| Achilles Therapeutics plc | -126.92 Million USD | -82.787% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -223.376% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -35280.416% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1016.79% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 16010.823% |
| Nutriband Inc. | -251.65 Thousand USD | -92088.971% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1661.446% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -3018.28% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 168.196% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1077.459% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 48.153% |
| Palisade Bio, Inc. | -12.06 Million USD | -1823.236% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -65.347% |
| Beam Therapeutics Inc. | -262.72 Million USD | 11.694% |
| Neurogene Inc. | -131.95 Million USD | -75.818% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1163.44% |
| AEON Biopharma, Inc. | -4.88 Million USD | -4654.098% |
| Sesen Bio, Inc. | -112.55 Million USD | -106.125% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -132.325% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -9781.621% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -494.475% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -178.572% |
| Athira Pharma, Inc. | -88.99 Million USD | -160.677% |
| Vaccinex, Inc. | -1.28 Million USD | -17912.422% |
| HCW Biologics Inc. | 2.85 Million USD | 8221.327% |
| XOMA Corporation | -29 Million USD | -700.0% |
| Nektar Therapeutics | 210.24 Million USD | 210.35% |
| Arvinas, Inc. | -313.8 Million USD | 26.068% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 14395.485% |
| Merus N.V. | -192.88 Million USD | -20.28% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 486.763% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -3243.903% |
| Rezolute, Inc. | -68.16 Million USD | -240.336% |
| Clene Inc. | 3.34 Million USD | 7046.108% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1659.308% |
| BeyondSpring Inc. | -13.75 Million USD | -1586.659% |
| Synlogic, Inc. | -6.68 Million USD | -3370.456% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 20558.554% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2643.938% |
| Peak Bio, Inc. | 10.34 Million USD | 2343.679% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -181.485% |
| Krystal Biotech, Inc. | -350.23 Million USD | 33.759% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 286.908% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -37.281% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -7248.414% |
| MannKind Corporation | 143.89 Million USD | 261.224% |
| Ikena Oncology, Inc. | -109.15 Million USD | -112.54% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2964.324% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -600.906% |
| Gossamer Bio, Inc. | 180.35 Million USD | 228.635% |
| CohBar, Inc. | -5.93 Million USD | -3811.828% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -679.884% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5181.034% |
| Legend Biotech Corporation | -949.39 Million USD | 75.563% |
| Mural Oncology plc | -255.84 Million USD | 9.319% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 820.161% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -4825.019% |
| Disc Medicine, Inc. | -358.28 Million USD | 35.246% |
| Champions Oncology, Inc. | 4.81 Million USD | 4921.28% |
| REGENXBIO Inc. | 54.76 Million USD | 523.605% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -86175.181% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -53.618% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2474.344% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -187.545% |
| Vaxart, Inc. | -8.24 Million USD | -2715.192% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -362.336% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -82.439% |
| Cellectis S.A. | -43.85 Million USD | -429.016% |
| Longeveron Inc. | -2.9 Million USD | -7877.992% |
| Repare Therapeutics Inc. | -107.85 Million USD | -115.098% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 123.958% |
| Inozyme Pharma, Inc. | 12 Million USD | 2032.689% |
| Revolution Medicines, Inc. | -608.2 Million USD | 61.855% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -18761.789% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 12.491% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -54.592% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1382.712% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -31251.351% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.574% |
| Denali Therapeutics Inc. | -74.86 Million USD | -209.891% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1834.671% |
| Veru Inc. | 4.77 Million USD | 4953.588% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1962.956% |
| Cingulate Inc. | 3.08 Million USD | 7625.912% |
| Passage Bio, Inc. | 4.58 Million USD | 5159.978% |
| Context Therapeutics Inc. | -14.44 Million USD | -1505.556% |
| Exicure, Inc. | 5.84 Million USD | 4066.49% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -0.705% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -486.303% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1578.555% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -294.417% |
| Nuvalent, Inc. | -335.38 Million USD | 30.826% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 13476.839% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -211.485% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2509.674% |
| OmniAb, Inc. | 9.2 Million USD | 2620.917% |
| Anew Medical, Inc. | 1.43 Million USD | 16295.858% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1516.21% |
| Lipocine Inc. | -4.75 Million USD | -4779.493% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -111.239% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1623.209% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -357.964% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1032.026% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -3351.867% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -252.439% |
| Ocugen, Inc. | -32.52 Million USD | -613.385% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -171.107% |
| Q32 Bio Inc. | -37.94 Million USD | -511.363% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -36842.675% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1614.835% |
| Equillium, Inc. | -22.39 Million USD | -936.084% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -807.384% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -611.073% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -93480.461% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 273.08% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 7354.534% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 70736.735% |
| Dominari Holdings Inc. | 195 Thousand USD | 119074.359% |
| Edesa Biotech, Inc. | -5.26 Million USD | -4304.86% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2501.772% |
| Bio-Techne Corporation | 267.74 Million USD | 186.649% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1331.304% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -96.454% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2660.919% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1733.847% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 5.352% |
| Nkarta, Inc. | 57.29 Million USD | 504.894% |
| BioCardia, Inc. | 212 Thousand USD | 109533.962% |
| Iterum Therapeutics plc | 13.43 Million USD | 1826.447% |